Isomorphic Labs | Alphabet wants to create drugs using AI

Isomorphic Labs

Alphabet created the company Isomorphic Labs with the aim of developing drugs using artificial intelligence

Alphabet, matrix of Google, created a new company of artificial intelligence call Isomorphic Labs with the aim of developing medicines.

According to the company, the idea is to “reimagine the discovery processes for new drugs.”

medicines

Isomorphic Labs was created after the achievements made with the artificial intelligence system from his sister company Deepmind, a research laboratory located in London. With this company, the most complete map of human proteins could be developed.

DeepMind’s artificial intelligence systems have been used for a variety of purposes. Ranging from neural networks that learn to play video games to providing voice recognition support to tools used on Android phones “

This new company will be based on the advances in artificial intelligence of DeepMind. Alphabet explained that with Isomorphic Labs seeks to “model and understand some of the fundamental mechanisms of life.”

Alphabet’s new company seeks to improve the process for creating medicines

Through a blog Demis Hassabis, founder and CEO of Isomorphic Labs, explained that the Covid-19 pandemic exhibited the importance of the work of scientists in the development of new drugs for the treatment of various diseases.

According to the CEO of Isomorphic Labs, the artificial intelligence It will help make research processes for drug creation faster.

“Not only to analyze data, but to build predictive and generative models of very complex biological phenomena”

artificial intelligence drugs

In the first moment Isomorphic Labs It will be focused on creating a group of multidisciplinary professionals in what they call “digital biology”.

They hope that in the future the new company of Alphabet can develop or assist in the creation of medications. For the cure of diseases that can now be fatal.

It should be remembered that Alphabet already has a presence in the pharmaceutical industry, with Verely a biotechnology unit that has focused on processing data. Also Calico, a life extension research firm.

Add Comment